Mistletoe therapy is an integrative cancer treatment used widely across Europe and now increasingly available in India through ABNOBA India. Developed by ABNOBA GmbH, a research-driven pharmaceutical company in Germany, this therapy uses extracts from the mistletoe plant (Viscum album), known for their unique immune-boosting properties.
At the core of mistletoe therapy is its ability to stimulate the immune system. The active compounds in mistletoe—such as mistletoe lectins and viscotoxins—trigger immune responses that help the body fight abnormal cells. These compounds promote the production of immune cells, such as T-cells and natural killer cells, which target and destroy cancerous cells more effectively.
Additionally, mistletoe therapy has shown potential in enhancing a patient’s overall well-being. Patients undergoing chemotherapy or radiation often experience fatigue, nausea, and loss of appetite. Mistletoe injections, typically administered subcutaneously, have been observed to help reduce these side effects, improving energy, mood, and quality of life.
Mistletoe therapy also supports apoptosis (natural cell death), which helps regulate abnormal cell growth. It’s not a substitute for primary cancer treatments like chemotherapy or surgery, but it plays a vital role in integrative care by strengthening the body's natural defenses and improving tolerance to conventional therapies.
ABNOBA India ensures access to pharmaceutical-grade mistletoe extracts that meet rigorous German quality standards. If you're exploring supportive therapies for cancer, mistletoe treatment may be a valuable addition to your care plan.
Learn more at www.abnoba.in
